Report
Ioannis Pontikis
EUR 100.00 For Business Accounts Only

Chr. Hansen Reports 2Q Results, Announces Pharma Joint Venture With Lonza; Shares Rich

Chr. Hansen reported second-quarter and semiannual results for fiscal 2019 with group sales growth of 8% (6% volume, 2% pricing) and 7% (6% volume, 3% pricing), respectively, broadly in line with our estimates. The company also announced the signing of an agreement with Lonza to create a strategic joint venture in the contract manufacturing market for bacteria-based pharmaceuticals (live biotherapeutics), which bonds well with the company's aspiration to further develop its human microbiome ligh...
Underlying
Chr. Hansen Holding A/S

Chr. Hansen is a biosciences group based in Denmark. Co. develops and supplies natural ingredient solutions for the food, pharmaceutical, nutritional, and agricultural industries worldwide. Co. operates in three divisions: Cultures and Enzymes (develops, produces, and sells cultures, enzymes, and probiotics for the food and dairy industries); Health and Nutrition (develops products for the dietary supplement, over-the-counter pharmaceutical, infant formula, and animal feed industries); and Natural Colors (develops natural color solutions to the food industry, primarily for the beverage, dairy, confectionery, fruit preparation and ice cream, as well as functional blends for processed meats).

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Ioannis Pontikis

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch